Evidence map›Paper›PMID 36722617›Full record

ArticleInquiry : a journal of medical care organization, provision and financing

Substantial Increase in Accessibility to Essential Anticancer Medicines in Anhui, China: A Longitudinal Study.

Rixiang Xu, Shuting Li, Tingyu Mu, Xuefeng Xie, Caiming Xu, Xiongwen Lv

Abstract read
In one paragraph

Article in Inquiry : a journal of medical care organization, provision and financing. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rixiang XuSchool of Huamanities and Management, Zhejiang Chinese Medical University, Zhejiang Province, China.ORCID 0000-0002-3869-5691
Shuting LiSchool of pharmacy, Anhui Medical University, Anhui Province, China.
Tingyu MuSchool of Nursing, Zhejiang Chinese Medical University, Zhejiang Province, China.
Xuefeng XieSchool of pharmacy, Anhui Medical University, Anhui Province, China.
Caiming XuSchool of Huamanities and Management, Zhejiang Chinese Medical University, Zhejiang Province, China.
Xiongwen LvSchool of pharmacy, Anhui Medical University, Anhui Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study aimed to evaluate the change in accessibility of essential anticancer medicines, from 2015 to 2018 in a pilot province for health care reform in China. Data on access to 23 essential anticancer medicines was obtained from 6 provincial tertiary hospitals. A comprehensive analysis was applied to explore these trends. The total utilization of anticancer medicines had increased by an average of 2.57 times (

Indexed as

Drugs, EssentialChinaHealth Care ReformHumansLongitudinal StudiesTertiary Care CentersDrugs, Essentialaccessibilityanticancer medicineChinaessential medicines

Identifiers

PMID36722617
PMCPMC9893346

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.